Ulcerative Colitis Clinical Trials

Showing 8481-8500 of 9,572 trials

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

NCT01040728

The study is intended to characterize the lung function profile of BI1744 in Chronic Obstructive Pulmonary Disease (COPD) patients where patients will perform pulmonary function tests at regular intervals for 24 hours at the end of a 6 week treatment period. Each patient will receive all four treatments.

Pulmonary Disease, Chronic Obstructive

Boehringer Ingelheim122 participantsStarted Jan 2010

Jasper, Alabama, United States • Clearwater, Florida, United States • Tampa, Florida, United States +9 more locations

COMPLETEDPhase 2

Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease

NCT01809262

Primary objective: To investigate bronchodilator effect and safety of single doses of BI 1744 CL inhaled via Respimat inhaler, Secondary objective: to characterize pharmacokinetics of BI 1744 CL. Olodaterol dose 40 mcg was investigated only in the open-label extension part for additional PK assessments which are not defined as primary or secondary endpoints.

Pulmonary Disease, Chronic Obstructive

Boehringer Ingelheim36 participantsStarted Dec 2005

Heerlen, Netherlands

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease

Related Searches

Evaluation of a New Medical Device AL539 in Patients With Obstructive Apneas Sleep Syndrome

Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I

Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease

Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD)

Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1

Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD)

Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD)

Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation

Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.

Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation

Oral Misoprostol Versus Vaginal Dinoprostone For Induction Of Labour: A Randomized Controlled Clinical Trial

Assessing the Symptoms of Obstructive Sleep Apnea

The Measurement of Intraocular Pressure in Normal Children Under General Anesthesia With and Without Nitrous Oxide and Anesthetic Eye Drops

The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

Relative Bioavailability of Olodaterol and Fluconazole

Interactive Study to Increase Glaucoma Adherence to Treatment